Answer
Yes, glucose intolerance has been reported with Enrylaze (recombinant crisantaspase); glucose levels should be monitored at baseline and periodically during treatment, with insulin administered as necessary for hyperglycaemia.
Sources for this answer
- Enrylaze 10 mg/0.5 ml Solution for injection/infusionJazz Pharmaceuticals UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked